BiotechTube
908 Devices

908 Devices

Boston, United States· Est.

908 Devices is revolutionizing chemical analysis by making it simple, smart, and speedy for critical, life-altering applications. Founded in 2012 and publicly traded on Nasdaq (MASS), the company leverages proprietary miniaturized mass spectrometry and FTIR technologies to deliver handheld devices that provide actionable intelligence in seconds. Its strategic focus is on high-impact markets including the illicit drug crisis, toxic chemical exposure, and global security threats, supported by a growing portfolio of products and strategic acquisitions.

908devices.com

Private Company

Total funding raised: $45M

AI Company Overview

908 Devices is revolutionizing chemical analysis by making it simple, smart, and speedy for critical, life-altering applications. Founded in 2012 and publicly traded on Nasdaq (MASS), the company leverages proprietary miniaturized mass spectrometry and FTIR technologies to deliver handheld devices that provide actionable intelligence in seconds. Its strategic focus is on high-impact markets including the illicit drug crisis, toxic chemical exposure, and global security threats, supported by a growing portfolio of products and strategic acquisitions.

Technology Platform

Proprietary High-Pressure Mass Spectrometry (HPMS) for miniaturized, handheld trace chemical detection, and Fourier-Transform Infrared (FTIR) spectroscopy for bulk substance identification.

Funding History

4
Total raised:$45M
IPOUndisclosed
Series C$25M
Series B$15M
Series A$5M

Opportunities

Growth is driven by the global illicit drug crisis, increasing security threats, and the need for faster hazmat response, creating demand for portable, high-performance chemical detectors.
The company can expand by selling more devices into existing government agencies, entering new international markets, and developing new applications for its core HPMS and FTIR technologies.

Risk Factors

Revenue is heavily dependent on government budget cycles and procurement processes.
The company faces intense competition from larger, established players in the chemical detection space.
Technological obsolescence and the need for continuous R&D investment present ongoing challenges.

Competitive Landscape

Main competitors include Smiths Detection, Bruker, Thermo Fisher Scientific, and Teledyne FLIR, which offer handheld Raman, FTIR, and GC-MS devices. 908 Devices differentiates through its proprietary, miniaturized High-Pressure Mass Spectrometry (HPMS) technology for trace detection and its combined HPMS/FTIR portfolio that addresses both trace and bulk analysis needs in rugged, user-friendly handheld formats.

More companies in Diagnostics & Precision Medicine →More companies in United States →